UTR Therapeutics plans to initiate a Phase 1 trial of UTRxM1-18 in patients with advanced c-MYC–driven tumors pending regulatory approvals. The company is also exploring translational and commercial ...

Cambridge-based startup CuspAI, which has just unveiled $100 million funding from global investors, was named Business of the ...

The biotechnology sector is entering a period of rapid growth and meaningful innovation. Global biotech revenue is expected to expand at roughly 13 to 14% annually over the next decade, moving from ...

Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1 Filing ...

Half Year ResultsNewron presents H1 2025 results and provides business update 16.09.2025 / 07:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Newron presents H1 2025 ...

This release is being retransmitted for extra exposure to downstream sites. SHELTON, CT / ACCESS Newswire / September 11, ...

Tallgrass Tech has donated $75,000 to Richland Community College to provide scholarships for engineering students.

The enteric nervous system (ENS), the largest division of autonomic nervous system, is a tantalizing frontier in neuroscience. With the advent of single-cell transcriptomics, the ENS has been ...

Students can select two additional subjects in Class 10 and only one subject in Class 12. Those students receiving additional ...

Innovation in RNA-based, immunotherapy and targeted therapeutics is not just aspirational, it's urgently needed. Aggressive cancers such ...

Simply banning unapproved AI may drive usage further underground, so forward-looking leaders are guiding AI experimentation ...

Study did not meet primary endpoint in change from baseline in mean daily oral corticosteroid (OCS) dose at week 48, although clinical benefit ...